Related Experiment Video
Updated: Feb 11, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Prognostic implications of peripheral artery disease in coronary artery disease
Olivia Manfrini1, Peter Louis Amaduzzi1, Edina Cenko1
1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Insights
Patients with coronary artery disease often have peripheral arterial disease, increasing cardiovascular event risk. Managing lipids aggressively and blood pressure carefully is crucial for better outcomes.
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Atherosclerosis Research
Background:
- Peripheral arterial disease (PAD) is more prevalent in patients with coronary artery disease (CAD) than in the general population.
- PAD severity correlates with increased risk of major cardiovascular events across various clinical settings.
- Both CAD and PAD share common cardiovascular risk factors and increased atherosclerotic burden.
Purpose of the Study:
- To investigate the relationship between PAD and CAD.
- To understand the impact of PAD on cardiovascular event risk.
- To evaluate the role of lipid-lowering and blood pressure management in patients with both conditions.
Main Methods:
- Observational analysis of patient data comparing prevalence and outcomes.
- Risk factor assessment and correlation with disease progression.
- Evaluation of therapeutic interventions, specifically lipid-lowering and blood pressure management.
Main Results:
- Higher prevalence of PAD in CAD patients.
- A graded increase in cardiovascular event risk with more affected arterial beds in PAD.
- Aggressive lipid-lowering therapy demonstrated reduced progression and increased regression of both CAD and PAD.
- Careful blood pressure management is indicated due to adverse outcomes associated with both high and low blood pressure values.
Conclusions:
- PAD is a significant comorbidity in CAD patients, amplifying cardiovascular risk.
- Aggressive lipid management is beneficial for both CAD and PAD.
- Blood pressure control requires careful titration to avoid adverse events.
Abstract:
Prevalence of peripheral arterial disease in patients with coronary artery disease is considerably higher than in the general population. A graded increase in the risk of major cardiovascular events in a variety of clinical settings is associated with the number of arterial beds affected by peripheral arterial disease. This is not surprising, considering that both coronary artery disease and peripheral arterial disease are linked to a higher prevalence of cardiovascular risk factors and a greater incidence of atherosclerotic burden. Aggressive lipid lowering therapy is associated with less coronary and peripheral arterial disease progression and greater regression. On the contrary, blood pressure therapy should be carefully managed, considering the association of both high and low values of pressure with adverse outcomes.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
04:40Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:30Peripheral Artery Disease I: Introduction
01:27Coronary Artery Disease V: Interprofessional Care
01:30Coronary Artery Disease III: Clinical Manifestations
01:26Coronary Artery Disease IV: Preventive Measures